Our Team

A passionate team of scientists.

Cajal is building a research and development team with the passion, drive, and scientific expertise to execute its bold mission of generating novel disease-altering therapies for neurodegeneration.

Leadership Team

Andrew Dervan, MD, MBA

Andrew Dervan, MD, MBA

Co-Founder and Co-Chief Executive Officer

Ian Peikon, PhD

Ian Peikon, PhD

Co-Founder and Co-Chief Executive Officer

Kimberly Scearce-Levie, PhD

Kimberly Scearce-Levie, PhD

Chief Development Officer

Leslie Aberman, JD

Leslie Aberman, JD

General Counsel

Ben Logsdon, PhD

Ben Logsdon, PhD

Vice President, Computational Biology

Valerie Huang, MBA

Valerie Huang, MBA

Vice President, Strategy & Corporate Development

J. Guy Breitenbucher, PhD

J. Guy Breitenbucher, PhD

Vice President, Chemistry

Team

Aaron Williams

Aaron Williams

Drug Discovery

Adebola Enikanolaiye

Adebola Enikanolaiye

Translational Models

Aishwarya Gogate

Aishwarya Gogate

Computational Biology

Anatoly Buchin

Anatoly Buchin

Computational Biology

Angelique Nelson

Angelique Nelson

In Vitro Screens

Anna Frolova

Anna Frolova

Finance

Anna Josephson-Day

Anna Josephson-Day

Facilities, EHS & Operations

Anna Minkina

Anna Minkina

Computational Biology

Arvis Sulovari

Arvis Sulovari

Computational Biology

Ashley Bockman

Ashley Bockman

Administration

Beatriz Saldana

Beatriz Saldana

Engineering

Bruno Grande

Bruno Grande

Engineering

Christian Gaetano

Christian Gaetano

Engineering

Christina Sanford

Christina Sanford

Drug Discovery

Devany Shikiar

Devany Shikiar

High Throughput Imaging

Drew Friedmann

Drew Friedmann

High Throughput Imaging

Eva Nachmanson

Eva Nachmanson

Finance

Hannah Hawks-Mayer

Hannah Hawks-Mayer

High Throughput Imaging

Ignas Cerniauskas

Ignas Cerniauskas

Target Validation

Jake Gockley

Jake Gockley

Computational Biology

Jen Whitesell

Jen Whitesell

Translational Models

Jennifer Luyapan

Jennifer Luyapan

Computational Biology

Jeremy Capalungan

Jeremy Capalungan

Drug Discovery

Johnny Goforth

Johnny Goforth

Target Validation

Karla Hirokawa

Karla Hirokawa

Translational Models

Kat Korvas

Kat Korvas

In Vivo Sciences

Kayla Hardwick

Kayla Hardwick

Computational Biology

Kyla Berry

Kyla Berry

Technology Development

Luke Funk

Luke Funk

In Vitro Screens

Madison Baird

Madison Baird

Viral Tools

Marcella Cline

Marcella Cline

Drug Discovery

Michael Kuranty

Michael Kuranty

In Vivo Sciences

Molly Lindbo

Molly Lindbo

In Vivo Sciences

Morgan Whelchel

Morgan Whelchel

In Vitro Screens

Nicole Sanford

Nicole Sanford

Drug Discovery

Nile Graddis

Nile Graddis

Engineering

Sadie Patraw

Sadie Patraw

Viral Tools

Sana Chintamen

Sana Chintamen

In Vitro Screens

Sarah Naylor

Sarah Naylor

Program & Alliance Management

Scott Shaffer

Scott Shaffer

Drug Discovery

Scott Simmons

Scott Simmons

Operations

Stephanie Dinh

Stephanie Dinh

In Vitro Screens

Thuc Nguyen

Thuc Nguyen

Target Validation

Ya-Lin Lu

Ya-Lin Lu

In Vitro Screens

Board of Directors

Rob Hershberg, MD, PhD

Rob Hershberg, MD, PhD

Co-Founder and Executive Chairman, Cajal Neuroscience

Susan Hockfield, PhD

Susan Hockfield, PhD

President Emerita, Massachusetts Institute of Technology

Josh Wolfe

Josh Wolfe

Co-Founder and Managing Partner, Lux Capital

Tim Kutzkey, PhD

Tim Kutzkey, PhD

Managing Partner, The Column Group

Jennifer Jarrett, MBA

Jennifer Jarrett, MBA

Chief Operating Officer, Arcus Biosciences

Scientific Advisory Board

Huda Zoghbi, MD

Huda Zoghbi, MD

Co-Founder and SAB Chair

Anthony Zador, MD, PhD

Anthony Zador, MD, PhD

Co-Founder

Charles Zuker, PhD

Charles Zuker, PhD

Co-Founder

Richard Hargreaves, PhD

Richard Hargreaves, PhD

Jay Shendure, MD, PhD

Jay Shendure, MD, PhD

David Holtzman, PhD

David Holtzman, PhD

Martin Kampmann, PhD

Martin Kampmann, PhD

Niranjan Bose, PhD

Niranjan Bose, PhD

Martin Burke, MD, PhD

Martin Burke, MD, PhD

Andrew Singleton, PhD

Andrew Singleton, PhD

We are proud to be backed by a set of world-class investors

  • Lux
  • The Column Group
  • Two Sigma Ventures
  • Evotec
  • Bristol Myers Squibb
  • Alexandria
  • Dolby Family Ventures

“All outstanding work, in art as well as in science, results from immense zeal applied to a great idea.”